Cited by

• Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer's disease.

  Lord J, Jermy B, Green R, Wong A, Xu J, Legido-Quigley C, Dobson R, Richards M, Proitsi P. Lord J, et al. Proc Natl Acad Sci U S A. 2021 Apr 20;118(16):e2009808118. doi: 10.1073/pnas.2009808118. Proc Natl Acad Sci U S A. 2021. PMID: 33879569 Free PMC article.
• Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease.

  Wu Q, Su S, Cai C, Xu L, Fan X, Ke H, Dai Z, Fang S, Zhuo Y, Wang Q, Pan H, Gu Y, Fang J. Wu Q, et al. Comput Struct Biotechnol J. 2023 Feb 24;21:1907-1920. doi: 10.1016/j.csbj.2023.02.041. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 36936813 Free PMC article.
• Exploring common genetic contributors to neuroprotection from amyloid pathology.

  Seto M, Mahoney ER, Dumitrescu L, Ramanan VK, Engelman CD, Deming Y, Albert M, Johnson SC, Zetterberg H, Blennow K, Vemuri P, Jefferson AL, Hohman TJ; Alzheimer’s Disease Neuroimaging Initiative. Seto M, et al. Brain Commun. 2022 Mar 17;4(2):fcac066. doi: 10.1093/braincomms/fcac066. eCollection 2022. Brain Commun. 2022. PMID: 35425899 Free PMC article.
• Leveraging machine learning predictive biomarkers to augment the statistical power of clinical trials with baseline magnetic resonance imaging.

  Lou C, Habes M, Illenberger NA, Ezzati A, Lipton RB, Shaw PA, Stephens-Shields AJ, Akbari H, Doshi J, Davatzikos C, Shinohara RT. Lou C, et al. Brain Commun. 2021 Nov 3;3(4):fcab264. doi: 10.1093/braincomms/fcab264. eCollection 2021. Brain Commun. 2021. PMID: 34806001 Free PMC article.
• Comparative Gene-Expression Analysis of Alzheimer's Disease Progression with Aging in Transgenic Mouse Model.

  Abid NB, Naseer MI, Kim MO. Abid NB, et al. Int J Mol Sci. 2019 Mar 11;20(5):1219. doi: 10.3390/ijms20051219. Int J Mol Sci. 2019. PMID: 30862043 Free PMC article.